Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting


You May Also Like

Blink Biomedical: Announces Close of Series A Funding

LYON, France, July 12, 2016 (GLOBE NEWSWIRE) -- BliNK Biomedical SAS ("BliNK"), a biopharmaceutical ...

Checkpoint Therapeutics to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co.

NEW YORK, April 27, 2017 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a ...